Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig R Rayner

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Parasites & Vectors|July 24, 2025
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety studyNicholas O Opoku, Felix Doe, Mannel E Agbogah, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Lancet Regional Health. Americas|December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Lancet Regional Health. Americas|November 12, 2025
Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142]Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silv, Daniela Carla Medeiros Silv, et al.
The New England Journal of Medicine|March 30, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19Gilmar Reis, Eduardo A S M Silva, Daniela C M Silva, et al.
The Lancet. Global Health|October 31, 2021
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, et al.
Annals of Internal Medicine|April 17, 2023
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
The New England Journal of Medicine|February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Parasites & Vectors|July 24, 2025
Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety studyNicholas O Opoku, Felix Doe, Mannel E Agbogah, et al.
British Journal of Clinical Pharmacology|February 9, 2017
Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemicsMohamed A Kamal, Patrick F Smith, Nathorn Chaiyakunapruk, et al.
Lancet Regional Health. Americas|December 20, 2021
Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: The TOGETHER randomized platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
Lancet Regional Health. Americas|November 12, 2025
Retraction notice to Effect of early treatment with metformin on risk of emergency care and hospitalization among patients with COVID-19: the TOGETHER randomized platform clinical trial [The Lancet Regional Health-Americas Volume 6, February 2022, 100142]Gilmar Reis, Eduardo Augusto Dos Santos Moreira Silv, Daniela Carla Medeiros Silv, et al.
The New England Journal of Medicine|March 30, 2022
Effect of Early Treatment with Ivermectin among Patients with Covid-19Gilmar Reis, Eduardo A S M Silva, Daniela C M Silva, et al.
The Lancet. Global Health|October 31, 2021
Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trialGilmar Reis, Eduardo Augusto Dos Santos Moreira-Silva, Daniela Carla Medeiros Silva, et al.
Annals of Internal Medicine|April 17, 2023
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform TrialGilmar Reis, Eduardo Augusto Dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
The New England Journal of Medicine|February 13, 2023
Early Treatment with Pegylated Interferon Lambda for Covid-19Gilmar Reis, Eduardo A S Moreira Silva, Daniela C Medeiros Silva, et al.
Pageof 7